Evidence map›Paper›PMID 40987296›Full record

ArticleAging cell2025

A Rare Hematopoietic Stem Cell-Derived Megakaryocyte Progenitor Accumulates via Enhanced Survival and Contributes to Exacerbated Thrombopoiesis Upon Aging.

Bryce A Manso, Paloma Medina, Stephanie Smith-Berdan, Alessandra Rodriguez Y Baena, Elmira Bachinsky, Lydia Mok, Angela Deguzman, Sarah Beth Avila, Connor Van Voorhis, Saran Chattopadhyaya and 4 more

Abstract read
In one paragraph

Article in Aging cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Bryce A MansoInstitute for the Biology of Stem Cells, University of California, Santa Cruz, California, USA.ORCID 0000-0002-4860-4888
Paloma MedinaInstitute for the Biology of Stem Cells, University of California, Santa Cruz, California, USA.
Stephanie Smith-BerdanInstitute for the Biology of Stem Cells, University of California, Santa Cruz, California, USA.
Alessandra Rodriguez Y BaenaInstitute for the Biology of Stem Cells, University of California, Santa Cruz, California, USA.
Elmira BachinskyInstitute for the Biology of Stem Cells, University of California, Santa Cruz, California, USA.
Lydia MokProgram in Biomedical Science and Engineering, University of California, Santa Cruz, California, USA.
Angela DeguzmanInstitute for the Biology of Stem Cells, University of California, Santa Cruz, California, USA.
Sarah Beth AvilaInstitute for the Biology of Stem Cells, University of California, Santa Cruz, California, USA.ORCID 0000-0001-7167-0704
Connor Van VoorhisInstitute for the Biology of Stem Cells, University of California, Santa Cruz, California, USA.
Saran ChattopadhyayaInstitute for the Biology of Stem Cells, University of California, Santa Cruz, California, USA.
Marcel G E RommelInstitute for the Biology of Stem Cells, University of California, Santa Cruz, California, USA.
Jenna MyersInstitute for the Biology of Stem Cells, University of California, Santa Cruz, California, USA.
Vanessa D JönssonBiomolecular Engineering, Baskin Engineering, University of California, Santa Cruz, California, USA.
E Camilla ForsbergInstitute for the Biology of Stem Cells, University of California, Santa Cruz, California, USA.ORCID 0000-0002-8740-4299

Funding

Defining the cause and consequence of aging-specific platelet specification from hematopoietic stem cellsR01AG062879 · NIA · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI CAMILLA FORSBERG · 2019 to 2026
$4.9M
IRACDA at UCSC and CSUMBK12GM139185 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI FORSBERG, CAMILLA, HINCK, LINDSAY E · 2020 to 2024
$4.1M
UCSC PREPR25GM104552 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI William T. SULLIVAN · 2013 to 2026
$3.9M
A postdoctoral training program for impactful careers in stem cell biologyT32HD108079 · NICHD · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI Bin Chen, CAMILLA FORSBERG · 2022 to 2026
$1.1M
CytoFLEX LX Cell AnalyzerS10OD030423 · OD · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI FORSBERG, CAMILLA · 2021 to 2021
$297k
California Institute for Regenerative Medicine EDUC4-12759Eunice Kennedy Shriver National Institute of Child Health and Human Development T32HD108079NIA NIH HHS K12GM139185NIA NIH HHS R01 AG062879NIA NIH HHS R01AG062879NIA NIH HHS R25GM104552NICHD NIH HHS T32 HD108079NIGMS NIH HHS K12 GM139185NIGMS NIH HHS R25 GM104552NIH HHS S10 OD030423the National Institutes of Health S10OD030423
6 · The paper itself

Abstract

Distinct routes of cellular production from hematopoietic stem cells (HSCs) have defined our current view of hematopoiesis. Recently, we and others have challenged classical views of platelet generation, demonstrating that megakaryocyte progenitors (MkPs) and ultimately platelets can be specified via an alternate and additive route of HSC-direct specification specifically during aging. This "shortcut" pathway generates hyperactive platelets likely to contribute to age-related platelet-mediated morbidities. Here, we used single-cell RNA/CITEseq to demonstrate that these age-unique, noncanonical (nc)MkPs can be prospectively defined and experimentally isolated from wild-type mice. Surprisingly, this revealed that a rare population of ncMkPs also exists in young mice. Young and aged ncMkPs are functionally distinct from each other and from their canonical (c)MkP counterparts, with aged ncMkPs paradoxically and uniquely exhibiting enhanced survival and platelet generation capacity. We further demonstrate that aged HSCs generate significantly more ncMkPs than their younger counterparts, yet this is accomplished without strict clonal restriction. Together, these findings reveal significant phenotypic, functional, and aging-dependent heterogeneity among the MkP pool and uncover unique features of megakaryopoiesis throughout life, potentially offering cellular and molecular targets for the mitigation of age-related adverse thrombotic events.

Indexed as

AgingHematopoietic Stem CellsMegakaryocyte Progenitor CellsThrombopoiesisAnimalsCell SurvivalMegakaryocytesMiceMice, Inbred C57BLagingblood plateletshematopoiesishematopoietic stem cellsmegakaryocyte progenitor cells

Identifiers

PMID40987296
PMCPMC12611322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.